Because its MTD was lower than the starting dose-level (400 mg/m2) and severe (grade 3 and 4) neutropenia prohibited any dose-escalation, prophylactic G-CSF was added to the PR-104-docetaxel combination in the next combination group. Here, CSF3 is linked to neutropenia.